Envestnet Asset Management Inc. Has $4.14 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA

Envestnet Asset Management Inc. cut its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 17.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 221,853 shares of the real estate investment trust’s stock after selling 45,592 shares during the period. Envestnet Asset Management Inc. owned approximately 0.09% of Sabra Healthcare REIT worth $4,135,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. State of Michigan Retirement System lifted its holdings in shares of Sabra Healthcare REIT by 1.1% during the 2nd quarter. State of Michigan Retirement System now owns 57,249 shares of the real estate investment trust’s stock valued at $1,056,000 after purchasing an additional 600 shares in the last quarter. Amalgamated Bank raised its holdings in Sabra Healthcare REIT by 0.6% during the 3rd quarter. Amalgamated Bank now owns 105,159 shares of the real estate investment trust’s stock worth $1,960,000 after buying an additional 612 shares during the period. Cherry Creek Investment Advisors Inc. lifted its stake in Sabra Healthcare REIT by 4.4% in the second quarter. Cherry Creek Investment Advisors Inc. now owns 19,074 shares of the real estate investment trust’s stock valued at $352,000 after buying an additional 802 shares in the last quarter. Ethos Financial Group LLC lifted its stake in Sabra Healthcare REIT by 1.3% in the second quarter. Ethos Financial Group LLC now owns 66,658 shares of the real estate investment trust’s stock valued at $1,229,000 after buying an additional 835 shares in the last quarter. Finally, Ballentine Partners LLC lifted its stake in Sabra Healthcare REIT by 6.4% in the third quarter. Ballentine Partners LLC now owns 14,438 shares of the real estate investment trust’s stock valued at $269,000 after buying an additional 870 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Trading Up 2.5%

Shares of NASDAQ:SBRA opened at $20.43 on Tuesday. The company’s 50-day moving average price is $19.17 and its two-hundred day moving average price is $18.85. Sabra Healthcare REIT, Inc. has a one year low of $15.75 and a one year high of $20.70. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The stock has a market capitalization of $5.15 billion, a PE ratio of 31.92, a price-to-earnings-growth ratio of 1.60 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The company had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same period in the prior year, the firm posted $0.36 EPS. Sabra Healthcare REIT’s revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Analyst Ratings Changes

Several brokerages have recently issued reports on SBRA. Cantor Fitzgerald increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 17th. Truist Financial upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research note on Tuesday, January 20th. Wells Fargo & Company lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Citigroup boosted their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Finally, Citizens Jmp increased their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.70.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.